Vnitr Lek 2013, 59(1):16-22

Outcomes of Catheter Ablation of Atrial Fibrillation in Patients over 65 Years of Age

M. Fiala1,2,*, L. Škňouřil1, O. Toman2, J. Pindor1, D. Wojnarová1, V. Bulková1, J. Chovančík1, M. Dorda1, H. Szymeczek1, R. Neuwirth1, D. Vavřík1, Š. Krawiec1, O. Jiravský1, L. Rybka2, R. Lábrová2, J. Januška1, J. Špinar2
1 Oddělení kardiologie Nemocnice Podlesí, a.s., Třinec, přednosta prim. MUDr. Marian Branny
2 Interní kardiologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Jindřich Špinar, CSc., FESC

Purpose:
This study assessed ablation techniques, recurrent arrhythmias, long-term outcomes, and complications of catheter ablation for atrial fibrillation (AF) in patients ≥ 65 years of age.

Methods:
Consecutive patients aged < 65 years (n = 653) vs ≥ 65 years (n = 213), who underwent catheter ablation of AF in the course of eight years, were compared. Ablation strategy and procedure endpoints were left at the operator's discretion.

Results:
The group of patients ≥ 65 years comprised more females (p < 0.001), and more frequently presented with persistent AF (p = 0.010). These patients less frequently underwent simple pulmonary vein isolation (p = 0.017); on the contrary, extensive ablation including coronary sinus intervention was more common (p = 0.020). There was no difference in repeat ablation procedures (25 % vs 26 % patients; p = 0.823, or 1.4 vs 1.5 ablation procedures/1 patients; p = 0.479, respectively). Spectrum of recurrent arrhythmias did not differ between the groups except for more frequent paroxysmal AF before the first repeat ablation in patients < 65 years (p = 0.050). At the end of 49 ± 26 month total follow-up, stable sinus rhythm (SR) was achieved in 85 % patients < 65 years vs 76 % patients ≥ 65 years (p = 0.318). To maintain stable SR, older patients more often continued to take antiarrhythmic medication (p = 0.054). More serious complication occurred in 3.8 % of the patients ≥ 65 years vs 2.1 % of the patients < 65 years of age (p = 0.207).

Conclusion:
Patients ≥ 65 years of age achieved insignificantly worse long-term outcome after insignificantly fewer repeat ablation procedures, and with more frequent use of antiarrhythmic drugs. SR maintenance and risk of complications were, however, favorable.

Keywords: atrial fibrillation; catheter ablation; age; outcomes

Received: September 7, 2012; Accepted: November 22, 2012; Published: January 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fiala M, Škňouřil L, Toman O, Pindor J, Wojnarová D, Bulková V, et al.. Outcomes of Catheter Ablation of Atrial Fibrillation in Patients over 65 Years of Age. Vnitr Lek. 2013;59(1):16-22.
Download citation

References

  1. Pappone C, Rosanio S, Augello G et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 2003; 42: 185-197. Go to original source... Go to PubMed...
  2. Wazni OM, Marrouche NF, Martin DO et al. Radiofrequency ablation vs. Antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005; 293: 2634-2640. Go to original source... Go to PubMed...
  3. Jais P, Cauchemez B et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 2008; 118: 2498-2505. Go to original source... Go to PubMed...
  4. Wokhlu A, Monahan KH, Hodge DO et al. Long-term quality of life after ablation of atrial fibrillation: the impact of recurrence symptom relief, and placebo effect. J Am Coll Cardiol 2010; 55: 2309-2316. Go to original source... Go to PubMed...
  5. Pappone C, Vicedomini G, Augello G et al. Radiofrequency catheter ablation and antiarrhythmic drug therapy: A prospective, randomized, 4-year follow-up trial: The APAF Study. Circ Arrhythm Electrophysiol 2011; 4: 808-814. Go to original source... Go to PubMed...
  6. Bulková V, Fiala M, Haman L et al. Zlepšení kvality života po ablaci dlouhodobě perzistentní versus paroxysmální fibrilace síní: výsledky dvouletého sledování. Vnitř Lék 2011; 57: 456-462. Go to PubMed...
  7. Berruezo A, Tamborero D, Mont L et al. Pre-procedural predictors of atrial fibrillation recurrence after circumferntial pulmonary vein ablation. Eur Heart J 2007; 28: 836-841. Go to original source... Go to PubMed...
  8. Tzou WS, Marchlinski FE, Zado ES et al. Long-term outcome after successful catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 237-242. Go to original source... Go to PubMed...
  9. The Atrial Fibrillation Follow up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833. Go to original source... Go to PubMed...
  10. The AFFIRM Investigators. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Circulation 2004; 109: 1509-1513. Go to original source... Go to PubMed...
  11. Fiala M, Chovančík J, Heinc P et al. Léčba symptomatické intermitentní fibrilace síní katetrovou ablací v levé srdeční síni: bezprostřední a dlouhodobé výsledky u 150 pacientů. Vnitř Lék 2005; 51: 971-983.
  12. Fiala M, Chovančík J, Nevřalová R et al. Pulmonary vein isolation using segmental versus electroanatomical circumferential ablation for paroxysmal atrial fibrillation: over 3-year results of a prospective randomized study. J Interv Card Electrophysiol 2008; 22: 13-21. Go to original source... Go to PubMed...
  13. Fiala M, Chovančík J, Nevřalová R et al. Termination of long-lasting persistent versus short-lasting persistent and paroxysmal atrial fibrillation by ablation. Pacing Clin Electrophysiol 2008; 31: 985-997. Go to original source... Go to PubMed...
  14. Cappato R, Calkins H, Chen SA et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 32-38. Go to original source... Go to PubMed...
  15. Fiala M, Chovančík J, Wojnarová D et al. Results of complex left atrial ablation of long-lasting persistent atrial fibrillation. J Interv Card Electrophysiol 2008; 23: 189-198. Go to original source... Go to PubMed...
  16. Bunch TJ, Weiss JP, Crandall BG et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in octogenarians. Pacing Clin Electrophysiol 2010; 33: 146-152. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.